These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 19762126)
21. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells]. Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798 [TBL] [Abstract][Full Text] [Related]
22. Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas. Ng EW; Aung MM; Abood ME; Martin BR; Razdan RK J Med Chem; 1999 Jun; 42(11):1975-81. PubMed ID: 10354405 [TBL] [Abstract][Full Text] [Related]
23. Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity. Balas L; Durand T; Saha S; Johnson I; Mukhopadhyay S J Med Chem; 2009 Feb; 52(4):1005-17. PubMed ID: 19161308 [TBL] [Abstract][Full Text] [Related]
24. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications. Snider NT; Walker VJ; Hollenberg PF Pharmacol Rev; 2010 Mar; 62(1):136-54. PubMed ID: 20133390 [TBL] [Abstract][Full Text] [Related]
25. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport. Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800 [TBL] [Abstract][Full Text] [Related]
26. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. Habayeb OM; Taylor AH; Bell SC; Taylor DJ; Konje JC Endocrinology; 2008 Oct; 149(10):5052-60. PubMed ID: 18599552 [TBL] [Abstract][Full Text] [Related]
27. The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon. Smid SD; Bjorklund CK; Svensson KM; Heigis S; Revesz A Eur J Pharmacol; 2007 Dec; 575(1-3):168-76. PubMed ID: 17706636 [TBL] [Abstract][Full Text] [Related]
28. Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown. Reggio PH Curr Med Chem; 2010; 17(14):1468-86. PubMed ID: 20166921 [TBL] [Abstract][Full Text] [Related]
29. Synthesis, cannabinoid receptor activity, and enzymatic stability of reversed amide derivatives of arachidonoyl ethanolamide. Parkkari T; Savinainen JR; Raitio KH; Saario SM; Matilainen L; Sirviö T; Laitinen JT; Nevalainen T; Niemi R; Järvinen T Bioorg Med Chem; 2006 Aug; 14(15):5252-8. PubMed ID: 16644227 [TBL] [Abstract][Full Text] [Related]
30. New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivo. Brizzi A; Brizzi V; Cascio MG; Corelli F; Guida F; Ligresti A; Maione S; Martinelli A; Pasquini S; Tuccinardi T; Di Marzo V J Med Chem; 2009 Apr; 52(8):2506-14. PubMed ID: 19331413 [TBL] [Abstract][Full Text] [Related]
31. Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism. Ortar G; Bisogno T; Ligresti A; Morera E; Nalli M; Di Marzo V J Med Chem; 2008 Nov; 51(21):6970-9. PubMed ID: 18831576 [TBL] [Abstract][Full Text] [Related]
32. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. Deutsch DG; Lin S; Hill WA; Morse KL; Salehani D; Arreaza G; Omeir RL; Makriyannis A Biochem Biophys Res Commun; 1997 Feb; 231(1):217-21. PubMed ID: 9070252 [TBL] [Abstract][Full Text] [Related]
33. Anandamide hydrolysis: a new target for anti-anxiety drugs? Gaetani S; Cuomo V; Piomelli D Trends Mol Med; 2003 Nov; 9(11):474-8. PubMed ID: 14604824 [TBL] [Abstract][Full Text] [Related]
34. Cannabimimetic plants: are they new cannabinoidergic modulators? Kumar A; Premoli M; Aria F; Bonini SA; Maccarinelli G; Gianoncelli A; Memo M; Mastinu A Planta; 2019 Jun; 249(6):1681-1694. PubMed ID: 30877436 [TBL] [Abstract][Full Text] [Related]
35. Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor. Hampson AJ; Hill WA; Zan-Phillips M; Makriyannis A; Leung E; Eglen RM; Bornheim LM Biochim Biophys Acta; 1995 Nov; 1259(2):173-9. PubMed ID: 7488638 [TBL] [Abstract][Full Text] [Related]
36. Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study. Ruiz-Llorente L; Ortega-Gutiérrez S; Viso A; Sánchez MG; Sánchez AM; Fernández C; Ramos JA; Hillard C; Lasunción MA; López-Rodríguez ML; Díaz-Laviada I Br J Pharmacol; 2004 Feb; 141(3):457-67. PubMed ID: 14718261 [TBL] [Abstract][Full Text] [Related]
37. Synthesis, in vitro and in vivo evaluation, and radiolabeling of aryl anandamide analogues as candidate radioligands for in vivo imaging of fatty acid amide hydrolase in the brain. Wyffels L; Muccioli GG; De Bruyne S; Moerman L; Sambre J; Lambert DM; De Vos F J Med Chem; 2009 Aug; 52(15):4613-22. PubMed ID: 19719235 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Kim J; Alger BE Nat Neurosci; 2004 Jul; 7(7):697-8. PubMed ID: 15184902 [TBL] [Abstract][Full Text] [Related]
39. Nuclear magnetic resonance for studying recognition processes between anandamide and cannabinoid receptors. Bonechi C; Martini S; Brizzi V; Brizzi A; Massarelli P; Bruni G; Rossi C Eur J Med Chem; 2006 Oct; 41(10):1117-23. PubMed ID: 16837109 [TBL] [Abstract][Full Text] [Related]